Connor, Clark & Lunn Investment Management (CC&L)’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.18M | Buy |
|
|||||
|
2025
Q1 | $6.22M | Buy |
|
|||||
|
2024
Q4 | $5.84M | Buy |
|
|||||
|
2024
Q3 | $5.18M | Sell |
|
|||||
|
2024
Q2 | $6.3M | Buy |
|
|||||
|
2024
Q1 | $4.67M | Sell |
|
|||||
|
2023
Q4 | $6.33M | Sell |
|
|||||
|
2023
Q3 | $9.49M | Buy |
|
|||||
|
2023
Q2 | $2.8M | Buy |
|
|||||
|
2023
Q1 | $968K | Buy |
|
|||||
|
2022
Q4 | $465K | Buy |
|
|||||
|
2022
Q3 | $102K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $246K | Sell |
|
|||||
|
2021
Q4 | $1.32M | Buy |
|
|||||
|
2021
Q3 | $678K | Buy |
|